We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider ...
Combination treatment with cadonilimab and lenvatinib can produce responses in patients with advanced endometrial cancer.
MedPage Today on MSN2d
Better Response, Survival in Head and Neck Cancer With Dual Pre-Op ImmunotherapyTwo neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single ...
A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
In the fourth episode of a six-part interview series on immunotherapy, Marc Voigt, CEO and Executive Director of Immutep (ASX ...
Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based ...
Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...
SAN DIEGO and SUZHOU, China, March 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today ...
The oncology therapy landscape is rapidly evolving, with immune checkpoint inhibitors�reshaping cancer treatment by leveraging the body's own immune system to combat tumors. As the immune checkpoint ...
The oncology therapy landscape is rapidly evolving, with immune checkpoint inhibitors reshaping cancer treatment by leveraging the body's own immune system to combat tumors. As the immune checkpoint ...
Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback